Bureau Of Labor Statistics Predicts Epidemiology Jobs Will Increase Significantly Because Of Changes Brought About By The COVID-19 Pandemic
In This Issue
A “boom” for epidemiologists and other health science jobs is how the New York Times characterized the latest employment projections from the Bureau of Labor Statistics.
-32020 Epi Salary Survey Results
In a February 2021 report on employment projections in a pandemic environment, the US Bureau of Labor Statistics projects that employment of epidemiologists will grow by about 31% between now and 2029. This projection did not change regardless of 2 whether the future scenario was one of
moderate or major impact from the changes in consumer spending behavior or workplace structural changes caused by the pandemic. Prior to the pandemic, the BLS had projected only a 4.6% growth in employment for epidemiologists. The percentage increase in jobs for epidemiologists is the largest increase among nearly 800 detailed occupations, according to the Times report. - BLS con't on page 2
CDC And Kaiser Data On COVID-19 Vaccination Show Nation Falling Short In Achieving Equity Goals Making sure that populations most at risk from COVID-19 cases, hospitalizations, and deaths are vaccinated first and receive a larger share of available vaccine has been a clearly articulated concern and goal from the earliest days of the pandemic. It is now a clearly stated goal of the Biden administration which has created a COVID-19 Health Equity Task Force.
It has also been clear that achieving such preferential vaccination would not be easy since several of the most vulnerable populations, including African Americans, Hispanic, and American Indian populations are among the most distrustful of government and the most reluctant to be vaccinated. - Goals cont'd on page 7
February 2021
•
Volume Forty Two •
Number Two
-9Interventions for Achieving Equity in COVID-19 Vaccination -10Near Term Epi Calendar -13Notes on People -15Marketplace
-BLS cont'd from page 1 The Epidemiology Monitor ISSN (0744-0898) is published monthly by Roger Bernier, Ph.D., MPH at 7033 Hanford Dr,, Aiken, SC, 29803, USA. Editorial Contributors Roger Bernier, PhD, MPH Editor and Publisher
Operations Linda Bernier, PhD, MS Operations Manager
Advertising Sales Linda Bernier, PhD, MS Director of Advertising 770.533.3436 linda@epimonitor.net Advertising Rates All ads listed below also include a banner ad on our website and in our EpiGram emails. Full Page $1,195 7.5”w x 10” h Half Page $895 7.5”w x 4.75” h Website Ad $495 / mo. Includes a banner ad in our EpiGram emails
more thorough evaluation of the impact of the pandemic on different industries and occupations.
Growth The projected growth in jobs for epidemiologists is part of an overall increased need for future pandemic preparation and medical research. At present, the BLS categorizes epidemiologists as a relatively “small” occupation with an estimated employment level of 8,000 as of 2019. Given the anticipated 31% increased growth, the BLS says this will add an estimated 2,500 new jobs over the next decade.
Type of Work Changes Among the changes impacting these projections are increased telework with its associated increased demand for information technology and computer related occupations and public demand for better prevention, containment, and treatment of infectious diseases. This latter demand will fuel increased scientific and medical research funding.
Other Medical
Losses
Other medical research occupations such as medical scientists who are not epidemiologists, biochemists, biophysicists, and biological technicians are also expected to grow. Of these, non-epidemiologist medical scientists are expected to add the most new jobs by increasing from an estimated 8,400 in the baseline scenario before the pandemic to 40,000 new jobs by 2029. According to the BLS, these numbers could change later in 2021 following a
Among the occupations expected to experience employment losses are cashiers, receptionists, information clerks, reservation and ticket agents, hotel, motel, resort desk clerks, waiters and waitresses, hosts and hostesses, bartenders, and cooks at institutions and cafeterias. In a strong impact scenario, entertainers are likely to suffer because of reduced attendance at concerts and other entertainment offerings. ■
Multi-month discounts available upon request.
Contact Us The Epidemiology Monitor 7033 Hanford Drive Aiken, SC 29803 USA 678.361.5170 editor@epimonitor.net
Do you have news about yourself, a colleague, or a student? Please help The Epidemiology Monitor keep the community informed by sending relevant news to us at this address for inclusion in our next issue. people@epimonitor.net
2
2020 National Epidemiology Academic Salary Survey By The University of Pennsylvania's Harvey Feldman, Glen Laferty & Lisbeth Dennis Today we share with readers the latest results of an innovative collaboration between the Epidemiology Monitor and the Center for Clinical Epidemiology and Biostatistics (CCEB) at the University of Pennsylvania’s Perelman School of Medicine. Now in its fourth year of partnership with this publication, this national survey of faculty salaries— designed to help leaders in departments of epidemiology and preventive medicine identify and promote competitive compensation for faculty members—continues to be an important and effective tool used to gather these data. As noted in the chart that accompanies this article, the survey returned salary data for 468 individuals from 25 departments across the nation. Key Findings Among the 25 reporting institutions, more than half are located at public universities. Eleven institutions were associated with a medical school or a university hospital. Compared to last year’s survey, fewer departments representing a smaller number of faculty members reported and there was lesser representation from larger midwestern institutions. Notably, when viewing median salaries, there was no consistent change among the title/years-inrank/sex-specific categories between 2019 and 2020. As expected, the data once again demonstrate higher salaries among more senior faculty ranks. Some other notable findings from this year’s survey include comparisons of non-physician salaries by sex. For most of the reporting categories median salaries for women are either similar or lower than for men, a pattern that was also observable in the 2019 data. As
well, although the data for physician salaries are relatively sparse, they appear broadly similar to nonphysician salaries at the ranks of assistant and associate professor and somewhat higher at the rank of professor. Evolving and Improving The CCEB began implementing this survey more than 20 years ago, soliciting data annually from across the nation to fill an unmet need. Few other large-scale surveys of faculty salaries are available as a national yardstick to help leaders in departments of epidemiology and preventive medicine identify and promote competitive compensation for faculty members. For the latest survey, the survey partners reached out, once again, to department chairs across the country to request data. Although the report should not serve as the sole basis for decision-making about compensation, we hope it will provide a useful perspective for assessing academic faculty salary levels in epidemiology.
"Few other largescale surveys of faculty salaries are available as a national yardstick..."
“...we hope it will provide a useful perspective..."
Future Surveys, Even Bigger Aims The CCEB and the Epidemiology Monitor strive to implement this survey to acquire salary data that are representative of US academic epidemiology faculty members and that reflect national trends. The success of the survey and its value in providing the field with a standard - Salary con't on page 4
3
-Salary cont'd from page 3 that can inform salary decisions depends on the rate of participation. We look forward to engaging even more respondents next year to gather a yet larger and more robust data set. Work will begin on the next survey in fall 2021, when epidemiology department chairs will receive a
2020 Epidemiology Survey All Schools (N= 25)
TITLE
Assistant Professor
YEARS IN RANK
Professor
TOTAL COUNT
Top, 1ST QUARTILE
MEDIAN
Top, 3RD QUARTILE
90TH PERCENTILE
29
$ $
105,000 95,000
$ $
112,875 117,667
$ $
126,000 130,000
$ $
134,804 134,400
2 to 3
44 Female 22 Male
66
$ $
100,306 104,144
$ $
117,936 112,234
$ $
129,634 135,467
$ $
149,348 139,050
4 to 5
26 Female 11 Male
37
$ $
93,400 91,918
$ $
103,716 113,050
$ $
120,438 122,265
$ $
140,000 138,444
27 Female 8 Male
35
$
100,737
$ $
118,500 118,074
$
134,506
$
154,187
0 to 1
12 Female 3 Male
15
$
128,644
$ $
134,893 142,000
$
153,836
$
161,460
2 to 3
26 Female 7 Male
33
$
120,199
$ $
133,177 145,000
$
156,000
$
169,781
4 to 5
23 Female 11 Male
34
$ $
126,000 134,612
$ $
130,171 149,730
$ $
160,000 166,767
$ $
190,022 179,014
33 Female 14 Male
47
$ $
122,321 136,079
$ $
140,108 150,832
$ $
169,261 159,978
$ $
203,694 219,348
0 to 1
10 Female 4 Male
14
$
162,200
$
188,686
$
246,513
$
285,000
2 to 3
6 Female 1 Male
7
$
225,000
4 to 5
13 Female 5 Male
18
41 Female 31 Male
72
6+
4
Non-Physician Salary Levels
17 Female 12 Male
6+
Professor
We are grateful to all of the departments contributing data to make this salary report possible. ■
0 to 1
6+
Associate
MALE/ FEMALE
request for data. Department chairs who would like to join the survey should contact The Epidemiology Monitor <editor@epimonitor.net>.
$
166,214
$ $
191,152 190,962
$
194,545
$
209,000
$ $
195,700 186,000
$ $
213,375 228,448
$ $
260,676 278,733
$ $
301,060 304,597
- Salary con't on page 4
2019 Epidemiology Survey All Schools (N= 25)
TITLE
Assistant Professor
YEARS IN RANK
TOP 1ST QUARTILE
MEDIAN
TOP 3RD QUARTILE
90TH PERCENTILE
46 female 22 male
68
95,790 102,838
114,947 115,004
125,000 122,000
155,000 131,800
2 to 3
52 female 25 male
77
102,000 90,456
114,712 110,698
126,400 127,184
155,000 139,050
4 to 5
37 female 9 male
46
97,375
116,448 127,900
123,940
134,506
29 female 11 male
40
96,588 105,000
105,765 113,121
117,601 125,000
133,900 135,300
0 to 1
19 female 11 male
30
122,210 145,000
128,125 150,000
145,000 182,327
150,000 200,000
2 to 3
35 female 14 male
49
119,796 110,254
135,000 131,235
158,321 153,830
169,261 171,600
4 to 5
30 female 14 male
44
115,640 122,485
124,887 134,754
137,600 150,000
172,425 164,800
43 female 29 male
72
131,403 122,443
142,125 153,555
159,217 161,800
171,369 201,791
0 to 1
9 female 6 male
15
149,592
160,000
185,000
203,400
2 to 3
13 female 11 male
24
182,900 131,128
188,976 154,352
210,000 205,000
266,000 208,200
4 to 5
13 female 7 male
20
160,500
213,375 251,678
220,000
240,000
180,660 185,000
208,701 216,400
230,000 244,314
260,000 318,778
6+
Professor
TOTAL COUNT
0 to 1
6+
Associate Professor
MALE/ FEMALE
Non-Physician Salary Levels
6+
48 female 64 male
112
- Salary con't on page 6
5
2020 Epidemiology Survey All Schools (N= 25)
TITLE
YEARS IN RANK
0 to 3 Assistant Professor 4+
0 to 3 Associate Professor 4+
0 to 3 Professor 4+
MALE/ FEMALE
Physician Salary Levels TOTAL COUNT
Top, 1ST QUARTILE
MEDIAN
2 Female 2 Male
4
$
132,637
4 Female 2 Male
6
$
115,687
3 Female 4 Male
7
$
127,853
5 Female 7 Male
12
$
151,830
3 Female 2 Male
5
$
245,000
7 Female 20 Male
27
$ $
264,744 245,444
$ 127,818
$ 213,000
2019 Epidemiology Survey All Schools (N= 25) TITLE
Assistant Professor
YEARS IN RANK 0 to 3
4+
Associate Professor
0 to 3
4+
0 to 3 Professor 4+
6
MALE/ FEMALE
Top, 3RD QUARTILE
90TH PERCENTILE
$ 214,200
$
$ 291,214
$ 329,264
281,750
Physician Salary Levels TOTAL COUNT
TOP 1ST QUARTILE
MEDIAN
3 female 2 male
5
102,000
5 female 4 male
9
112,990
5 female 4 male
9
204,800
8 female 12 male
20
153,320 143,235
2 female 4 male
6
14 female 33 male
47
117,143
TOP 3RD QUARTILE
90TH PERCENTILE
153,928
160,000
224,032 265,369
330,878 294,080
222,335
164,866 189,500
200,632 239,035
-Goals cont'd from page 1 New Reports Now two extensive reports by the Centers for Disease Control and Prevention (CDC) and the Henry J Kaiser Family Foundation (KFF) conclude that racial disparities in COVID-19 vaccinations are emerging and, according to CDC, “equity in access to COVID-19 vaccination has not been achieved nationwide.” CDC has just announced a plan to invest 2.25 billion dollars over two years to address COVID-19 related health disparities and advance health equity among populations that are at high-risk and underserved, including racial and ethnic minority groups and rural populations. MMWR CDC findings were published in the Morbidity and Mortality Weekly Report on March 17, 2021. The agency examined over 49 million first doses of COVID vaccination where county of residence was available. Vaccination coverage was 1.9% percentage points higher in counties classified as having a low social vulnerability index compared to counties with a high social vulnerability (15.8% vs 13.9%). At the state level, only Arizona and Montana actually had higher vaccination coverage in high vulnerability counties for all elements of the social vulnerability index used by CDC. Three other states Alaska, Minnesota, and West Virginia also scored well. Vaccination disparities in in one or more of the composite elements of the social vulnerability measure were found in 31 states.
The Vulnerability Index The indicators making up the vulnerability index resulted in four themes including socioeconomic status, household composition and disability status, racial/ethnic minority status and language, and housing type and transportation. The theme most associated with percentage differences was socioeconomic status, and within this category the most influential socioeconomic indicator was the percentage of adults without a high school diploma. Kaiser In the Kaiser data collected from 44 states which report data on race/ethnicity and COVID vaccinations, several states showed that Black and Hispanic persons received smaller shares of vaccinations compared to their shares of cases and deaths and compared to their shares of the total population. KFF cited as examples California where 21% of vaccinations have gone to Hispanic people while Hispanics account for 55% of cases, 46% of deaths, and 40% of the total population. In another example, similar disparities were found for African Americans in the District of Columbia. States that have smaller shares of Hispanic and African American populations tended to have smaller differences, according to KFF. In 39 states with available data, KFF found that overall the vaccination rate among white people was over twice as high as the rate for Hispanic people ( 19% vs 9%) and nearly twice as high as the rate for Black people (19% vs 11%). The size of these differences varies widely across states. As positive news, the relative differences in the overall totals across reporting states has narrowed since March 1, says Kaiser. ■
“...the most influential socioeconomic indicator was the percentage of adults without a high school diploma."
“...the vaccination rate among white people was over twice as high as the rate for Hispanic people..."
7
Multiple Interventions Being Investigated Or Proposed To Achieve Equity In COVID-19 Vaccination According to the Centers for Disease Control and Prevention (CDC), monitoring community level characteristics of COVID-19 vaccinations is going to be essential in tailoring specific interventions which can reduce inequities. Among possible causes for the inequities cited by CDC are access problems such as vaccine supply, vaccination clinic availability, and lack of prioritization. Other challenges relate to vaccine hesitancy among different subpopulations for a variety of reasons which are not well understood. Guide
“CDC proposes three strategies for building vaccine confidence..."
In a new guide prepared by CDC entitled “COVID-19 Vaccine Confidence Rapid Community Assessment Guide” CDC proposes three strategies for building vaccine confidence: • Building trust through credible, clear communications. • Empowering healthcare personnel to be confident in their own decision to be vaccinated and to successfully recommend the vaccine to their patients . • Engaging communities and individuals in a sustainable, equitable, and inclusive way, using two-way communication to reinforce trust in health authorities and build confidence in COVID-19 vaccines. Interventions
8
Among the interventions CDC described in states with high equity
vaccination results are the following: 1) prioritizing persons in racial/ethnic minority groups early on, 2) actively monitoring and addressing barriers to vaccination in vulnerable communities, 3) directing vaccines to vulnerable communities, 4) offering free transportation to vaccination sites, and 5) collaborating with community partners, tribal health organizations and the Indian Health Service. According to CDC, “more investigation is needed to understand these differences to identify best practices to achieve COVID-19 vaccination equity.” Hopkins Project One investigation currently underway at the Johns Hopkins University sponsored by the Robert Wood Johnson Foundation is entitled “Understanding Diverse Communities and Supporting Equitable and Informed COVID-19 Vaccination Decision Making.” [Disclosure: The Epi Monitor is a consultant to Hopkins]. The framework for the Hopkins project identifies the usual factors considered important to address in vaccination programs such as filling information gaps people have around COVID-19 vaccines and removing obvious - Interventions con't on page 9
- Interventions cont'd from page 8 barriers to vaccination such as lack of transportation and language differences. Both of these can impact decisions to get vaccinated or not, but the Hopkins framework also highlights the need to interact with members of the public in genuine two-way communication as recommended in the CDC guide. The Hopkins project conducted neutrally facilitated “community conversations” which acknowledged and respected the different values and experiences individuals brought to the discussions and impacted their decision making about COVID-19 vaccination. Respect As stated in 2013 by Kathleen Hall Jamieson, Professor of Communication and Director of the Annenberg Public Policy Center at the University of Pennsylvania at a Science of Science Communication Colloquium at the National Academy of Sciences, “You can’t persuade someone you don’t respect.” (Epi Monitor, October 2013) Public Engagement Other experts are also making the case for the importance of genuine public engagement with members of the public on vaccine related topics. A recent op-ed in the New York Times by Heidi Larson, an expert on vaccine confidence, states that “In our scientific rush to develop, manufacture, and deliver vaccines more rapidly than ever in history, countries around the world have failed to engage the public.” Also, “Few countries have coherent national strategies, but they are necessary. These strategies need to involve the public, not only as vaccine recipients, but as actors in the process.
COVID vaccines cannot be seen as something taken because the government says so, but because they have meaning in people's lives.” White House View Local or community dialogues have been identified as important to carry out by Andy Slavitt, White House Senior Advisor for the COVID Response Team. He noted in a recent CNN interview that as the US vaccine supply increases and demand for vaccination possibly fails to keep up, local dialogues will be needed to interact directly with people. Slavitt also pointed out that some members of the public, especially conservatives, don’t want an authority to try to convince them to take the vaccine. They don’t want to feel like they’re being manipulated but rather feel like they’re getting straight answers from trustworthy sources, said Slavitt. These observations highlight the importance of neutral facilitation and respectful dialogue in genuine public engagement processes. ■
"...countries around the world have failed to engage the public.”
“They don’t want to feel like they’re being manipulated..."
Join us on our Facebook page at: https://bit.ly/2U29gUA
9
Near Term Epidemiology Event Calendar Every December The Epidemiology Monitor dedicates that issue to a calendar of events for the upcoming year. However that often means we don't have full information for events later in the upcoming year. Thus an online copy exists on our website that is updated regularly. To view the full year please go to: http://www.epimonitor.net/Events The events that we are aware of for the next two months follow below.
April 2021 April 6 - May 25 http://bit.ly/2DZ37CP Conference / Health Effects International 2021 Conference / HEI / VIRTUAL April 7-16 https://bit.ly/3p3hMCw Conference / SHEA (Society for Healthcare Epidemiology of America) Spring 2021 / SHEA / VIRTUAL April 10-15 http://bit.ly/3gQCH8N Conference / 2020 Annual Meeting American Association for Cancer Research (Note - this is part 1 of this conference and part 2 runs in May) / AACR / VIRTUAL April 19-20 https://bit.ly/2VRFqoZ Conference / ISPE 2021 Mid-Year Meeting / International Society for Pharmacoepidemiology / VIRTUAL April 19-23 http://bit.ly/2sePrRj Short Course / Surveillance for Public Health / Emory University SPH / VIRTUAL April 21-23 http://bit.ly/2K4p3Dl Short Course / Mendelian Randomization (B) / University of Bristol / VIRTUAL April 22-23 http://bit.ly/3amAReU Conference / The Impact of Climate Change on Infectious Disease / Washington University St. Louis / VIRTUAL April 24-27 http://bit.ly/2DZtMPU Conference / 55th Annual Meeting of the European Diabetes Epidemiology Group (EDEG) / EDEG / Hersonissos, Crete, Greece April 26-27 http://bit.ly/2K4p3Dl Short Course / Essentials of Infectious Disease Modelling and Economic Evaluation / University of Bristol / VIRTUAL April 28-30 http://bit.ly/2K4p3Dl Short Course / Questionnaire Design, Application and Data Interpretation / University of Bristol / VIRTUAL
Help complete the epi calendar for 2021 The events listed below in blue have traditionally run in April each year. As of the date of publication, we cannot locate updated information for these specific events for 2021. We will be updating our calendar monthly throughout 2021. If you have any information on these events please contact us at events@epimonitor.net Please check our website and newsletter issue often for new information.
Short Course / Mendelian Randomization / University of Bristol / http://bit.ly/352CzfT Short Course / Epidemiology of Infectious Diseases / Erasmus MC / https://bit.ly/2UAKEUf Short Course / Cancer Epidemiology / Erasmus MC / https://bit.ly/2Eeb0Wg Short Course / Child Psychiatric Epidemiology / Erasmus MC / https://bit.ly/2rvWLEz
May 2021 May 4-20 http://bit.ly/34gLGZh Conference / APHL 2021 / Association of Public Health Laboratories / VIRTUAL May 10-11 http://bit.ly/2K4p3Dl Short Course / Multiple Imputation for Missing Data / University of Bristol / VIRTUAL May 10-28 https://bit.ly/3d36Gc4 Short Course / Modeling Food Safety and Animal Health Risks Using R / EpiX Analytics / VIRTUAL May 15-19 http://bit.ly/3oVSpT3 Conference / Preventive Medicine 2021 / American College of Preventive Medicine / Washington, DC May 16-19 http://bit.ly/36gZsMC Conference /42nd Annual Meeting / Society for Clinical Trials / Chicago, IL May 17-21 http://bit.ly/3gQCH8N Conference / 2021 Annual Mtg American Association for Cancer Research (Part 2) / AACR / VIRTUAL May 17 - June 4 http://bit.ly/2P1VUrR Summer Program / Summer Public Health Institute / University of Minnesota / Minneapolis, MN May 24-25 http://bit.ly/344s0Ya Conference / 5th International Molecular Pathological Epidemiology (MPE) Meeting / Multiple / VIRTUAL May 31 - June 2 http://bit.ly/33YKQQx Short Course / Cardiovascular Epidemiology / Erasmus MC / VIRTUAL May 31 - June 4 http://bit.ly/2RvLH8H Conference / 46th Annual Kettil Brunn Society Meeting / Kettil Brunn Society / Helsinki, Finland May 31- June 4 http://bit.ly/34kMPl6 Conference / 10th SE Asia & Western Pacific TEPHINET Scientific Conference / TEPHINET / Taipei, Taiwan May 31 - June 18 http://bit.ly/38mW6tl Summer Program / Infectious Disease and Global Health / McGill University / Montreal, Canada
Help complete the epi calendar for 2021 The events listed below in blue have traditionally run in May each year. As of the date of publication, we cannot locate updated information for these specific events for 2021. We will be updating our calendar monthly throughout 2021. If you have any information on these events please contact us at events@epimonitor.net Please check our website and newsletter issue often for new information.
Short Course / Psychopharmacology / Erasmus MC / https://bit.ly/2JTrTuh Conference / 69th Annual Epidemic Intelligence Service Conference CANCELLED FOR 2021 / CDC / http://bit.ly/38nmB26 Conference / International Epidemiology Conference / Athens Institute for Education & Research / http://bit.ly/2E0NTxe Short Course / Training Course on Epidemiological Data Analysis Using STATA / Data-Afrique Consultancy / http://bit.ly/2YBlM0U
11
May 2021 continued Conference / 14th Interest Conference (HIV) / IeDEA / http://bit.ly/2DXzS3d Conference / International Society for Radiation Epidemiology and Dosimetry, Inaugural Meeting / National Cancer Institute / http://bit.ly/36p0O8o Conference / WREN 2021 / Western Regional Epidemiology Network / http://bit.ly/2E2bYn2 Conference / 73rd World Health Assembly / WHO / http://bit.ly/2PuSCMM Summer Program / Summer Program on Modern Methods in Biostatistics & Epidemiology / BiostatEpi / http://bit.ly/2PtVfhM
Epidemiology Events Do you have an event of interest to the epi community? Please help The Epidemiology Monitor keep the community informed by sending your event information to us for inclusion in the calendar on our website and in the monthly issue of The Epidemiology Monitor http://www.epimonitor.net/Events.htm events@epimonitor.net Linda Bernier / 770.533.3436
12
Notes on People Do you have news about yourself, a colleague, or a student? Please help The Epidemiology Monitor keep the community informed by sending relevant news to us at this address for inclusion in our next issue. people@epimonitor.net
Elected: Christian Abnet, to the American Epidemiological Society. Dr Abnet is Chief of the Metabolic Epidemiology Branch in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute. According to the NCI, Dr Abnet is an international expert in the etiology of esophageal and gastric cancers. His studies have focused on the effects of diet, environmental exposures, and genone-wide association studies of common genetic variation and cancer risk.
Died: Stanley Foster, of bone marrow disease on March 14, 2021. Dr. Foster was a former CDC Epidemic Intelligence Service Officer with a colorful and varied career in smallpox eradication, international health, and as faculty member at the Rollins School of Public Health. CDC’s principal deputy director Anne Schuchat noted “Stan’s frontline leadership in the eradication of smallpox made the virus history.”
Elected: Lindsay Morton, to the American Epidemiological Society. Dr Morton is Deputy Chief of the Radiation Epidemiology Branch in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute. According to NCI, Dr Morton is internationally recognized for groundbreaking research on hematologic malignancies and multiple primary cancers. Speaking of her and Dr Abnet above, NCI Division Director Stephen Chanock said “this prestigious honor was bestowed upon two very fitting leaders in epidemiology.”
Profiled: Syra Madad, in Aljazeera News as “The epidemiologist and her fight to prevent the next pandemic”. Dr Mada is Senior Director of the System-wide Special Pathogens Program at NYC Health + Hospitals. In the article, Dr Madad’s appearance in Netflix’s docuseries “Pandemic: How To Prevent an Outbreak” is highlighted.
13
- People cont'd on page 14
Notes on People, continued from page 13 Do you have news about yourself, a colleague, or a student? Please help The Epidemiology Monitor keep the community informed by sending relevant news to us at this address for inclusion in our next issue. people@epimonitor.net
Michael Osterholm, in the Minneapolis Star as “Pandemic predictor Michael Osterholm gives us science and the hope to cope with it.”Osterholm is Director of the University of Minnesota’s Center for Infectious Disease Research and Policy. In the profile, Osterholm says “This isn’t a pandemic of just a virus…This is a pandemic of emotion. This is a pandemic of pain and suffering that has to do with lost jobs and lost persons…This is not just a public health journey. This is a personal journey for all of us.”
Newsmaker: Jennifer Dillaha, described on local media in Arkansas as someone who went from being "an everyday epidemiologist to a health hero". Dr Dillaha is Arkansas State Epidemiologist and Medical Director for Immunizations and Outbreak Response for the Arkansas Department of Public Health. Reflecting on the past year of pandemic challenges, Dillaha told KNWA “ Some of us were reflecting today on the gratitude we have for being able to play a role that we’re trained for, were prepared for…It hasn’t always been fun. Sometimes it’s been really hard work.”
Your Ad Should Be Here Do you have a job, course, conference, book or other resource of interest to the epidemiology community? Advertise with The Epidemiology Monitor and reach 35,000 epidemiologists, biostatisticians, and public health professionals monthly Advertising opportunities exist in this digital publication, on our website and Facebook page, and in our Epi-Gram emails.
Linda Bernier, Director of Advertising / 770.533.3436 / linda@epimonitor.net
14
Senior Scientist Distinguished Scientist
The BC Cancer Research Institute (BC Cancer) invites applications for a full-time (1.0 FTE) faculty position at the rank of either Senior or Distinguished Scientist. The successful candidate must be eligible for a faculty appointment at a BC Cancer Partner University, such as Simon Fraser University and/or the University of British Columbia. BC Cancer will facilitate this appointment process. BC Cancer, a part of the Provincial Health Services Authority, is committed to reducing the incidence of cancer, reducing mortality from cancer, and improving the quality of life for those living with cancer. It provides a comprehensive cancer control program for the people of British Columbia by working with community partners to deliver a range of oncology services, including prevention, early detection, diagnosis and treatment, research, education, supportive care, rehabilitation and palliative care. For more information, visit www.bccancer.bc.ca. We are seeking a translational senior or distinguished scientist in lung cancer screening and prevention using individual and population data. The successful candidate will be expected to engage in a multi-disciplinary program of epidemiological, data sciences and translational research. The candidate must be committed to building an integrative research program within the Lung Cancer Research Program at BC Cancer, emphasizing discovery and translation of lung cancer screening and novel prevention approaches to maximize the clinical potential of modern cancer control strategies. The specific objective is to improve treatment outcomes for high-risk cancer patients by leveraging collaborations with established, world-leading programs at the departments of Integrative Oncology and Cancer Control Research and other research departments at BC Cancer and Partner University. The Partner University will be dedicated to the pursuit of excellence in public health while providing an engaging environment for our community of scholars and trainees actively working to advance translational research from basic science to medical applications. Candidates for this position must hold a PhD or MD/PhD degree in mathematics, epidemiology or related area, with postdoctoral research experience. The successful candidate will have demonstrated research skills and research excellence in the area of lung cancer screening and prevention with an established track record and professional experience in cancer prevention and control and cancer risk assessment. Moreover, demonstrated knowledge in public health policy modeling, decision modeling, simulation modeling, statistical inference and dynamic systems will be considered an asset. As a Senior Scientist/Distinguished Scientist at BC Cancer and as a faculty member at a Partner University, the successful applicant will be expected to have an established strong externally-funded and internationally-competitive research program, collaborate with other faculty members, and actively participate in service to the Research Institute, the University, and the academic/scientific community. The candidate will also need to show demonstrated ability to achieve excellence in teaching and will be expected to participate in the undergraduate, graduate and postgraduate teaching activities at the Partner University in their field of expertise. Salary will be commensurate with qualifications and experience. Applicants should send a cover letter, curriculum vitae, detailed summary of research interests and impact of anticipated research program (maximum 5 pages), statement of teaching accomplishments and interests, and have at least 3 reference letters (one must not be a co-author). Equity and diversity are essential to academic excellence. An open and diverse community fosters the inclusion of voices that have been underrepresented or discouraged. We encourage applications from members of employment equity seeking groups as enumerated under the B.C. Human Rights Code, including sex, sexual orientation, gender identity or expression, racialization, disability, political belief, religion, marital or family status, age, and/or status as a First Nation, Metis, Inuit, or Indigenous person.
Applications should be addressed to: François Bénard, MD Vice President Research, BC Cancer
Applications and questions should be sent to: Ms. Laura Florio Research Administration, BC Cancer lflorio@bccrc.ca
Your Ad Should Be Here Do you have a job, course, conference, book or other resource of interest to the epidemiology community? Advertise with The Epidemiology Monitor and reach 35,000 epidemiologists, biostatisticians, and public health professionals monthly Advertising opportunities exist in this digital publication, on our website and Facebook page, and in our Epi-Gram emails.
Linda Bernier, Director of Advertising / 770.533.3436 / linda@epimonitor.net
TWO ASSISTANT / ASSOCIATE PROFESSOR POSITIONS Tenure Stream The Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh invites applications for two full-time faculty positions at the level of Associate/Assistant Professor in the tenure stream. The positions are available immediately and requires a doctoral degree in Epidemiology or a related discipline with post-doctoral training in Epidemiology. Review of applications will commence upon receipt of all application materials and will continue until the position is filled. Please apply by going to www.join.pitt.edu and applying for the requisition numbers below. Please attach a cover letter, curriculum vitae, a statement of current and future research directions, and the names of three references to your online application. The University of Pittsburgh is an Affirmative Action/ Equal Opportunity Employer and values equality of opportunity, human dignity and diversity, EOE, including disability/vets. EPIDEMIOLOGY METHODS Requisition # 20006032 The candidate should demonstrate skills in coursework design and teaching advanced theory and methods for the analysis of epidemiological data. Of particular interest are candidates who focus on pedagogy and educational program development. Successful candidates will be responsible for leading independent research including the development and application of novel epidemiologic and statistical methods. Research areas of interest include, but are not limited to, causal inference methods, inverse probability weighting, g-computation methods, mediation analyses, prediction models, machine learning, and Bayesian adaptive designs. Candidates should have training and experience in the design and analysis of cohort studies and/or clinical trials elucidating the environmental, behavioral, social, or biologic determinants of disease or in evaluating the effectiveness of interventions. The position will require that the candidate obtain independent research grant funding, publish manuscripts, and develop an independent program of research. Candidate will also teach and mentor master and doctoral degree students within the Epidemiology program. In addition to the qualifications above, appointment at the Associate Professor level requires five years of experience and demonstrated scholarly productivity, including teaching, funded research, and extensive publications in peer-reviewed journals. Salary will be commensurate with experience. MOLECULAR EPIDEMIOLOGY Requisition #20006010 This position is designed to leverage and sustain a growing research program in cardiovascular epidemiology in African ancestry populations. Of particular interest are candidates with skills in molecular epidemiology and assessment of subclinical cardiovascular disease. Successful candidates will establish independent research and develop and apply novel epidemiologic approaches in ongoing or new cohort studies. Candidates should have training and experience in the design and management of cohort studies and in the genetic as well as other biological, environmental, behavioral, and social determinants of disease. Candidates with experience in working with foreign institutions are preferred. The position will require that the candidate obtain independent research grant funding, publish manuscripts, and sustain an independent program of research. The candidate will also lead graduate courses and mentor master and doctoral degree students within the Epidemiology program. In addition to the qualifications above, appointment at the Associate Professor level requires five years of experience and demonstrated scholarly productivity, including teaching, funded research, and extensive publications in peer-reviewed journals. Salary will be commensurate with experience.
Columbia University's Department of Epidemiology has a summer institute every June called episummer@columbia that enables anyone anywhere in the world to engage in the worldclass coursework and high-quality instruction offered at Columbia University. It provides opportunities to gain foundational knowledge and applied skills for advancing population health research. episummer@columbia’s intensive short courses are offered in synchronous or asynchronous online learning formats. Registrants for episummer@columbia courses need access to high-speed internet. Specific information about online access is provided to registrants before the course begins.
episummer@columbia: synchronous learning Our synchronous courses vary in length from 4 hours to 20 hours delivered in an online live format. These courses are offered only on a specific date and time allowing registrants the ability to interact live with their episummer@columbia course instructor and other registrants.
episummer@columbia: asynchronous learning Each asynchronous course, varying in length from 5 hours to 40 hours, contains lectures and course material presented online with materials released by the instructor accordingly. The flexible format will include video or audio recordings of lecture material, file sharing and topical discussion fora, self-assessment exercises, real-time electronic office hours and access to instructors for feedback during the course.
Detailed information on the program:
http://bit.ly/3osj5Kn
Registration for 2021 is open:
http://bit.ly/2WdMtIy
Your Ad Should Be Here Do you have a job, course, conference, book or other resource of interest to the epidemiology community? Advertise with The Epidemiology Monitor and reach 35,000 epidemiologists, biostatisticians, and public health professionals monthly.
Advertising opportunities exist in this digital publication, on our website and Facebook page, and in our Epi-Gram emails.
For more information please contact: Linda Bernier, Director of Advertising / 770.533.3436 / linda@epimonitor.net
The Epidemiology Monitor in a Digital Version is available FREE to subscribers The Epidemiology Monitor is available exclusively online in the same familiar print format subscribers are accustomed to, and they can read through the publication on their electronic devices in the same manner they did with the print version. In addition, you’ll be able to download and save copies of The Epidemiology Monitor for easy future access. Over the next year we’ll be exploring ways to make this publication available on additional mobile devices.
This publication format provides: ►
Easier access to information that is more timely
►
Publication alerts via email
►
Embedded hot links in articles
►
Full color advertising
►
Wider circulation for advertisers
SUBSCRIBE FOR FREE TODAY AT: http://epimonitor.net/Subscribe.htm